Point-of-care Capillary Blood Lactate Measurements in Human Immunodeficiency Virus–uninfected Children With In Utero Exposure to Human Immunodeficiency Virus and Antiretroviral Medications-Reference-Cited by-同舟云学术

Point-of-care Capillary Blood Lactate Measurements in Human Immunodeficiency Virus–uninfected Children With In Utero Exposure to Human Immunodeficiency Virus and Antiretroviral Medications

Published:2011-12 Issue:12 Volume:30 Page:1069-1074
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Crain Marilyn J.,Williams Paige L.,Griner Ray,Tassiopoulos Katherine,Read Jennifer S.,Mofenson Lynne M.,Rich Kenneth C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health

Reference39 articles.

1. . Natural history of hyperlactataemia in human immunodeficiency virus-1-infected patients during highly active antiretroviral therapy.;Huynh;Scand J Infect Dis,2003

2. . Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors.;Moyle;AIDS,2002

3. Lactic acidemia in infection with human immunodeficiency virus.;Carr;Clin Infect Dis,2003

4. . Lack of recurrence of hyperlactatemia in HIV-infected patients switched from stavudine to abacavir or zidovudine.;Lonergan;J Acquir Immune Defic Syndr,2004

5. . Glucose production, oxidation and disposal correlate with plasma lactate levels in HIV-infected patients on HAART.;Haugaard;J Infect,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial Toxicity in Children and Adolescents Exposed to Antiretroviral Therapy;Mitochondrial Dysfunction Caused by Drugs and Environmental Toxicants;2018-02-23

2. Capillary blood for point-of-care testing;Critical Reviews in Clinical Laboratory Sciences;2017-07-04

3. Mitochondrial compromise in 3-year old patas monkeys exposedin uteroto human-equivalent antiretroviral therapies;Environmental and Molecular Mutagenesis;2016-07-25

4. The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs;Frontiers in Immunology;2016-05-23

5. Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States;AIDS Research and Human Retroviruses;2016-04